Skip to main content

14.05.2025 | Originalie | Online-Artikel

Osteoimmunology: A Paradigm Shift in Oral Surgery

verfasst von: Dr. Elisa Choukroun DDS, Dr. Joseph Choukroun MD

Introduction

The term “Osteology” was introduced in 1594 by Barthelemy Cabrol, a French anatomist, in his work “Alphabet Anatomic”. In 2000, the principles of “osteoimmunology” were introduced by Arron and Choi [1]:  the immune system is involved in bone synthesis and remodeling cascades, where it controls bone formation, regulates bone resorption and acts as a key factor in bone homeostasis [2,3]. Inversely, immune cells functions are influenced by the bone system [4]. It has been concluded that bone system and immune system are unified into a single entity: the osteo-immune system [5].
One of the consequences of an impaired immune response is the delay or failure of osseointegration [10]. Bone management cannot be achieved without an efficient immune response. Bone loss around implants (early or late) should be regarded as an immune mechanism.
Moreover immune cells and factors are the key regulators in wound healing and contribute to the early stages of angiogenesis. [6,7].

Inflammation: the key word

For a clinical perspective, we can ask 2 questions:

1.    How the immune system becomes deficient?
2.    What happens when immunity fails?

Osseointegration and wound healing begin with an immune reaction: inflammation. which is always beneficial through the activation of the cells repair genes.
In a physiological way, inflammation should end before the 5th day by the action of the antioxidants [8]. While inflammation is always beneficial during the first days, its persistence after the 5th day will create a harmful situation, with increase of oxidants production, leading to a deficient immune response. When the response is deficient, wound healing and bone formation are compromised, as osteoblasts are inhibited and osteoclasts activated. Thus, bone loss becomes mandatory, through the failure of bone remodeling. A defective immune system leads to a delayed or failed osseointegration, a rise in infections incidence and fibrosis. Fibrosis and connective tissue growth are consequences of a long-term inflammation [9].

Clinical answers:

1.    The immune system becomes deficient when inflammation persists, leading to an increase of oxidants production.
2.    When the immune system is deficient, the rate of failures or complications rises (bone loss, delayed osseointegration, fibrosis, infections.

Oxidants, antioxidants & oxidative stress

Oxidation-reduction (redox) reactions occur constantly in living creatures. Most take place inside the mitochondria, which continuously produce endogenous free radicals, also known as oxidants or ROS for Reactive Oxygen Species. ROS are a highly reactive group of molecules, by leakage in their outer shell of a single impaired electron. They are generated as by-products of aerobic metabolism [10,11]. At low concentrations, ROS are beneficial as they serve as signaling molecules to activate specific physiological pathways, controlling numerous life processes [12,13]. At higher concentration, they interfere with lipids, lipoproteins, proteins and nucleic acids, creating both molecular and cellular damages.

Besides, the human body balances oxidants with antioxidants. Antioxidants are low weight molecules able to counteract oxidation, either by preventing ROS formation, or scavenging/neutralizing ROS by providing the missing electron. Antioxidants can be produced endogenously or be provided by exogenous oral supplementation. One of the main benefit of antioxidants is their ability to down-regulate pro-inflammatory cytokines, reducing inflammation without side effects.

Antioxidants production is mostly controlled by Nrf2 (Nuclear Factor Erythroid-2-Related Factor 2), a transcription factor regulating over 500 human genes [14], which mainly controls damage repair processes and reduces inflammation by increasing antioxidants production. Recent studies have highlighted the crucial role of Nrf2 in osteoporosis, osteogenic stem cells differentiation and bone fracture healing [15,16]. Conversely, impaired Nrf2 nuclear translocation is associated with delayed cortical bone healing [17].

The term “oxidative stress” appeared in the medical literature in 1985 [18]. It is defined when oxidants and antioxidants levels are imbalanced and ROS production exceeds cellular antioxidant defenses [19,20]. Free radicals are produced in quantity under several conditions including tissue damage repair, pollutant exposure, unbalanced diet, anxiety, smoking or chronic inflammation. Oxidative damage to bio-macromolecules plays an active role in the etiology of a wide variety of acute and chronic diseases [21]. It plays a central role in the acceleration of the ageing process and in osteoporosis [22-24]. It has been proved to deteriorates the correct immune system functioning [25] and to increase the occurrence rate of numerous and diverse pathologies, such as cancer, arthritis, cardiovascular diseases, neurodegenerative troubles and may induce uncontrollable autoimmune illnesses [26-30].
Antioxidants, on the other hand, have opposite effects: they enhance mineralization processes and reduce the osteoclastic activity, either directly or by counteracting oxidants effects [31]. 

Oxidative Stress and Bone

Bone remodeling follows a complex cycle that lasts for approximately six months. Under normal circumstances, the cycle is regulated by cytokines, growth factors and hormones [32]. Elevated amounts of free radicals in osteoblasts inhibit their functions [33,34] and lead to apoptosis of both osteoblasts and osteocytes [35]. ROS also play a crucial role in osteoclast differentiation and function [36,37]. Excessive osteocytes apoptosis and increased osteoclastogenesis counteract osteogenesis and mineralization. As the bone remodeling turnover increases, bone loss is facilitated.

Level of oxidants is related to the inflammation level.
Oxidation of immune cells will lead to immune deficiency.
The success in dental implants or bone augmentations procedures logically depends on the amount of antioxidants produced.

Osteoimmunology

Osteoimmunology is based on the strong connections found between the bone and immune systems [38].  Immune and bone cells have a conjoined heritage in stem cells: they share signaling pathways and influence each other permanently [39]. Immune system controls bone and its resorption and thus acts as a key factor in bone homeostasis [2,3].

In periodontium, microbial dysbiosis alone is not sufficient to trigger periodontitis. Immune cells, by activating periodontal ligament cells, enable the expression of molecules including RANKL, and thus osteoclastic activity [40]. Indeed, activation of non-specific immune defenses will provoke an inflammatory reaction. T-lymphocytes have been identified as the cells responsible for bone renewal, both in periodontitis and in other pathologies [41,42]. They actively engage macrophages and then RANKL via osteoclasts. Patients with periodontitis, compared with healthy patients, have T-lymphocytes overexpressing RANKL and TNF alpha: this overexpression is responsible for osteoclastic activity and associated bone loss [43].

Neutrophils also play a role in the production of free radicals, in RANKL expression and in the progression of chronic inflammation, not just acute inflammation as has long been recognized [44].
Conversely, immune cells and factors are also key regulators of wound healing and contribute to the early stages of angiogenesis [45,46].

After a bone fracture, immune cells, especially macrophages, are found throughout the healing process, organizing the body’s defense against pathogens [47]. Fracture healing starts through an inflammatory reaction, induced by the release of leukocyte inflammatory cytokines, predominantly angiogenic [48]. After angiogenesis onset, the granulation tissue, also named “soft bone callus”, is formed [49]. However, two conditions are required for this cascade of events to occur: a sufficient amount of antioxidants, and a proper activation of repair genes [50].

Oxidative stress and immune deffiency in oral surgery

Inflammation is still the key phenomenon. Oxidation systematically follows long term inflammation, which can result from both local or systemic conditions. 
Elevated ROS levels, either associated to metabolic diseases, chronic ischemia or inflammation, damage immune cells and thus compromise immune functions, affecting bone formation and maintenance.

Oxidative Stress following systemic inflammation

Globally, chronic inflammatory diseases (autoimmune diseases, diabetes, allergy, obesity, Human Immunodeficiency Virus ect..) are responsible of systematic oxidative stress.

- Diabetes, as a chronic inflammatory disease [51], induces oxidative stress through hyperglycemia [52]. Diabetics healing issues, periodontal fragility and systemic complications (including nephropathy, neuropathy, angiopathy) are related to their oxidation level [53].

- Tobacco smoke: its contact with tissues such as skin, lung or oral tissues, breaks down antioxidants [54]. Smoke exposure impairs the oxidant/antioxidant balance in oral tissue and raises the release of pro-inflammatory cytokines [55]. Resulting inflammatory response and oxidative stress in peri-implant tissue induces delayed wound healing and increased risk of peri-implantitis.

- Penicillin allergy, as any form of allergy is an immune dysfunction, in which patients don’t recruit enough neutrophils to ward off pathogens. On the other hand, activated T-lymphocytes continuously release pro-inflammatory cytokines [56]. Resulting chronic inflammation and limited prophylaxis engender a three-to-four fold increased risk of surgical site infection, compared to non-allergic patients [57]. Indeed, alternatives to amoxicillin do not show an equivalent efficiency [58]. 
Moreover, allergic patients are often deficient in vitamin D, and thus in chronic oxidative stress [59].
        
- Vitamin D deficiency is also a major factor in ROS production. Vitamin D is in reality an hormone, synthesized mainly after UV radiations on skin. Normal serum level range is between 30 to 100ng/mL (or 75 to 250nmol/mL) [60]. Vitamin D levels influence cell growth and stimulates antioxidants production [61]. By promoting Nrf2 accumulation and activation, vitamin D enhances the expression of numerous gene regulating immunity and bone growth and remodeling [62,63]. It has also been shown to have antimicrobial and anti-inflammatory properties [64,65]. Vitamin D deficiency is widespread. Identified risk factors are : age, dark skin, depression, obesity, smoking, diabetes, allergy, kidney insufficiency. Vitamin D deficiency significantly impact the osseointegration and success rate of dental implants therapies and bone grafts outcomes [66-69].
        
- Hypercholesterolemia. LDL cholesterol is an oxidant, known to promote artherosclerosis.
Studies have reported the association between elevated LDL and alterations of the functions of bone-forming osteoblasts and osteoporosis [70, 71,72]. 
Its accumulation into osteoblasts slows down bone metabolism and synthesis, driving stem cells to produce fat cells. Bone becomes fatty, taking a yellowish color.
In contrast, High-Density Lipoprotein (HDL) cholesterol acts as an antioxidant [73-75].

Oxidative Stress following local inflammation

- Inflammatory soft tissues : In patients with thin phenotype, the junctional epithelium is permeable to bacteria, and pathogens can penetrate and spread to the periodontium, inducing long-term inflammation [76]. Long term inflammation and the resulting underlying bone oxidation generate resorption, either in native or grafted bone.
Indeed, in grafted bone, when submitted to inflammatory soft tissues or to periodontium contamination during the healing period, fibrosis sets in [77]. 

- Foreign body reaction is a common consequence of biomaterials use. They have the potential to induce adverse immune reactions, resulting in excessive inflammation, impaired healing, fibrotic encapsulation, tissue destruction, or even isolation and rejection of medical devices [78]. 
Biomaterials foreign body reaction depends on their biocompatibility [79], and thus can be categorized in two types, based on their immunogenicity: 
Human, allogenic or porcine bone have low immunogenicity resulting in low inflammation and oxidation processes.
On the other hand, other xenogeneic substitutes (such as bovine) have good biological activity, but the elimination of immunogenic reactions while retaining osteogenic abilities is challenging : inflammation persists for a long time, leading to fibrosis and connective tissue formation [80]. Synthetic materials are subject to degradation, which exposes a fresh surface to oxidants released by macrophages and foreign body giant cells. The persistence of the foreign body reaction, which occurs at the interface between the tissue and the biomaterial over time, suggests a continuous oxidation process, albeit at low levels [81].

- Chronic hypoxia is another source of oxidant production. Tissues usually become hypoxic by losing their vasculature when exposed to overpressure or tension [82].
Cortical bone blood supply is organized by the soft tissue through the periosteum. Therefore, any soft tissue tension will lead to the underlying bone hypoxia and condemn it to resorb [83].
Soft tissue traction can occur with inconsistent flap release after bone augmentations, inadapted suture technique or lack of keratinized attached gingiva [84].
Implant placement, with high primary stability, might as well create bone compression. Cancellous bone is flexible, thus few stress is induced even if implants are placed with high torque. In contrast, cortical bone is a rigid tissue with a reduced blood supply. Consequently, pressure will cause hypoxia and oxidation especially if the cortical bone is thick [85]. This is the mechanism of marginal bone loss/ 
Regarding grafted bone, bone matrix becomes stiff after few months. Mechanically, the regenerated bone has lower flexibility and behaves as a cortical bone. When it is submitted to pressure, it will resorb.

Review of solutions to improve immune response lower oxidative stress

In the field of oral surgery, better understanding of osteoimmunology permits guidelines and protocols proposal to enhance bone formation, reduce complications or failures and to achieve long term stability. 
The key word is anti-inflammation. The strategy is to reduce or stop inflammatory mechanisms and sources.

Why the use of anti-inflammatory drugs is not a good solution?

Because they are immuno-suppressive. Clinical side effects of long term anti-inflammation are well known: osteoporosis, infection and delayed wound healing [86,87]

Systemic improvement of immune response

Antioxidation is one of the ways to enhance immune system and to reduce inflammation length.

- External antioxidants or nutraceuticals have demonstrated their ability to decrease oxidative damages. Oral antioxidants alone have shown a significant reduction of up to 40% in oxidative stress blood serum markers, especially in smokers, patients at higher risk [88].
Exogeneous antioxidants can be classified in two groups: those with Nrf2 activation functions and those with direct antioxidative properties:
It had been proven that Nrf2 activators hold the potential to control the inflammatory-driven bone loss [89,90]. Among those activators, we can find vitamin D, vitamin C, melatonin, and zinc. [91-98].
Other nutraceuticals can be prescribed to patients, to increase endogenous antioxidants production and thus down-regulates pro-inflammatory cytokines, such as probiotics, vitamin K2, vitamin E, vitamin B6, copper, magnesium, and fatty acids [99-104].

Micronutrients and nutraceuticals could enhance peri-implant wound, bone healing and stability, and therefore dental implant osseointegration and long-term success [105]. Their supplementation have to be considered in bone reconstructions, especially on patients with systemic disorders (diabetes, auto immune or inflammatory diseases) and should start at least ten to fifteen days before surgery. 

- Reduction of serum LDL cholesterol: hypercholesterolemia has been identified as a risk factor for dental implants stability and must be treated before surgery if LDL serum levels exceed 1.4g/l [106]. Treatment can be achieved through administration of a combination of cholesterol-lowering medications improvement of lifestyle (exercise, low-saturated-fat diet, not smoking, drastic reduction of alcohol and red meat consumption).

- Among immunomodulatory antibiotics, azithromycin is a well-known antibiotic from the macrolide family, discovered in 1980 and which immunomodulatory functions were published in 1987. It is retrieved in high concentrations in phagocytic cells and fibroblasts, enabling activity against microorganisms and pathogens in infected sites [107].
Aside from its antimicrobial effects, azithromycin exerts anti-inflammatory activities and may be of therapeutic benefit in various inflammatory disorders by inhibiting oxidative stress, inflammation and apoptosis. It improves epithelial barrier dysfunctions and promotes connective tissue remodeling [108]. When administered as a pre-operative prophylaxis, a single dose of azithromycin generates higher active substance concentrations in periodontal tissues and greater inhibition of inflammatory mediators at peri-implant wound sites, compared to amoxicillin [109].

- Autophagy describes cell regeneration under fasting conditions. This concept brought the Nobel prize to Christian de Duve in 1974 [110] and then recently to Yoshinori Ohsumi in 2016. When fasting, cells undergo autophagy, forming unusually large vacuoles that function as "cell dumps", collecting and recycling unwanted substances [111]. Autophagy improves both innate and adaptative immune responses and accelerates wound healing through angiogenesis.
Intermittent fasting, lasting at least 16 hours a day (by skipping the breakfast for example) represents a straightforward and effective way to harness the benefits of autophagy for our patients.

- Physical exercise: It is known that physical exercise improves global health through the improvement of immune system. Indeed, exercise permits the mobilization of both hematopoietic and mesenchymal stem cells into several tissue such as bone marrow, fat and synovia. These cells are the main immune cells. Hematopoietic stem cells produce the white cells, responsible of the adaptive and innate immune systems [112]. Mesenchymal stem cells regulate both innate and adaptive immune systems.
Walking is the most efficient type of physical exercise. However, it must be done at least 30 minutes per day and at a sustained pace (around 3 steps/second) [113].

Local improvement of immune response 

Surgical management should be performed to avoid local oxidation.
- Growth factors and PRF are used routinely in oral surgery and various medical fields. Platelet-rich fibrin (PRF), prepared without anticoagulant, represents the simplest and most efficient method, as it combines platelets, leukocytes and a fibrin matrix [114]. PRF induces angiogenesis and anti-inflammation pathways; possesses osteogenic properties and inhibits osteoclastogenesis [115,116]. Recent studies indicate that the main mechanism of action of PRF lies in its antioxidant promotion and thus improves local immune responses [117,118]. 
Additionally, PRF enables constitution of a sticky bone graft. By reducing the mobility of the graft (induced by muscle activity), it avoids inflammation coming from the bone callus fragmentation. 
Finally, the fibrin matrix can be used to perform an open wound technique, where wound closure is voluntarily not achieved and PRF membranes are used to fill the gap between soft tissue edges.
It promotes a secondary wound healing cascade and an increased width of keratinized mucosa.

- Low inflammatory biomaterials: to avoid inflammation and its deleterious consequences, oral surgeons should prefer the use of low inflammatory biomaterials, such as human or porcine bone, over alloplastic or other xenogeneic bone grafts [80]. 

- Implant placement should avoid contact between the crestal cortical bone and the implant neck, by either overdrilling the cortical bone or placing implants subcrestally. New implant designs tend to present narrower neck and facilitate pressure less positioning near the crestal bone. Similarly, when dealing with grafted bone at re-entry, the same attention and protocols must be applied. During implant placement in a dense bone graft, a reduced torque and crestal overdrilling should be performed, to avoid graft stress caused by implant pressure.

- Tension free sutures and flap closure must be applied on every occasion, to avoid ischemia. Flap release is a critical step of the surgery and requires careful consideration to guarantee a tensionless situation. Wound closure and suture technique should respect PASS principles as described by Wang: primary closure, angiogenesis, space creation/maintenance and stability [119]. Bone grafts outcomes rely the application of such principles.

Conclusion

Osteoimmunology significantly widened the knowledge on bone health and diseases, shedding light on the intricate interplay between bone and immune system. Researchers hope that the interdisciplinary nature of osteoimmunology will lead to major discoveries in bone regeneration and the development of targeted therapies for bone diseases.
Osteoimmune supportive protocols, described in this article, include biologic patient preparation, use of azithromycin, Platelet-Rich-Fibrin low inflammatory biomaterials, and surgical behaviors such as pression and tension awareness. Applying these protocols could decrease the incidence of peri-implantitis and increase dental implants success rate.
Osteoimmunology have provided valuable insights into periodontitis pathogenesis and may offer a new perspective on the understanding of peri-implantitis, as they both present similar symptoms: chronic inflammation of the periodontal tissue and subsequent destruction of the alveolar bone around teeth or implants.
However, the lack of randomized clinical studies or such protocols in the current scientific literature, underscores the necessity for further scientific research and validation. Additional studies must analyze the impact of nutraceuticals on the prevention of periimplantitis.


Literatur

1. Arron JR, Choi Y (2000). Bone versus immune system. Nature 408(6812):535–6 

2.    Suda T, Takahashi N, Udagawa N et al (1999) Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20(3):345–57 

3.    Yasuda H, Shima N, Nakagawa N et al (1999) A novel molecular mechanism modulating osteoclast differentiation and function. Bone 25(1):109–13 

4.    Yang N, Liu Y (2021) The Role of the Immune Microenvironment in Bone Regeneration. Int J Med Sci 18(16):3697–3707 

5.    Okamoto K, Nakashima T, Shinohara M (2017) Osteoimmunology: The Conceptual Framework Unifying the Immune and Skeletal Systems. Physiol Rev 97(4):1295–1349 

6.    Su L, Zheng J, Wang Y et al (2019) Emerging progress on the mechanism and technology in wound repair. Biomedicine & Pharmacotherapy 117:109191 

7.    Ribatti D, Crivellato E (2009) Immune cells and angiogenesis. J Cell Mol Med13(9A):2822–33 

8.    Landén NX, Li D, Ståhle M (2016) Transition from inflammation to proliferation: a critical step during wound healing. Cell Mol Life Sci 73(20):3861–85 

9.    Hajishengallis G, Sahingur SE (2014) Novel inflammatory pathways in periodontitis. Adv Dent Res 26(1):23–9 

10.    Giorgio M, Migliaccio E, Orsini F (2005) Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 122(2):221–33 

11.    Auten RL, Davis JM (2009) Oxygen toxicity and reactive oxygen species: the devil is in the details. Pediatr Res 66(2):121–7 

12.    Finkel T, Holbrook NJ (2000) Oxidants, oxidative stress and the biology of ageing. Nature 408:239–247 

13.    Sardaro N, Della Vella F, Incalza MA et al (2019) Oxidative Stress and Oral Mucosal Diseases: An Overview. In Vivo 33(2):289–296 

14.    Robledinos-Antón N, Fernández-Ginés R, Manda G, Cuadrado A (2019) Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development. Oxid Med Cell Longev 9372182 

15.    Yang R, Li J, Zhang J (2023) 17β-estradiol plays the anti-osteoporosis role via a novel ESR1-Keap1-Nrf2 axis-mediated stress response activation and Tmem119 upregulation. Free Radic Biol Med 195:231–244 

16.    Wang L, Liang Y, Zhou X et al (2023) Nrf2 differentially regulates osteoclast and osteoblast differentiation for bone homeostasis. Biochem Biophys Res Commun 674:19–26 

17.    Nabeshima T, Tsukamoto M, Wang KY et al (2023) Delayed cortical bone healing due to impaired nuclear Nrf2 translocation in COPD mice. Bone 173:116804 

18.    Sies H (1985) Oxidative stress. London: Academic Press 

19.    Glasauer A, Chandel NS (2013) ROS. Curr Biol 23:R100–R102 

20.    Valko M, Leibfritz D, Moncol J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44–84 

21.    De Boer J, Andressoo JO, de Wit J (2002) Premature aging in mice deficient in DNA repair and transcription. Science 296(5571):1276–9 

22.    Iantomasi T, Favilli F, Catarzi S, Vincenzini MT (2001) GSH role on platelet-derived growth factor receptor tyrosine phosphorylation induced by H2O2. Biochem Biophys Res Commun 280(5):1279–85 

23.    Blanco RA, Ziegler TR, Carlson BA et al (2007) Diurnal variation in glutathione and cysteine redox states in human plasma. Am J Clin Nutr 86:1016–1023 

24.    Koh JM, Lee YS, Byun CH et al (2005) Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio in human bone marrow stromal cells. J Endocrinol 185:401–413 

25.    Brunetti G, D'Amelio P, Mori G, Faienza MF (2020) Editorial: Updates on Osteoimmunology: What's New on the Crosstalk Between Bone and Immune Cells. Front Endocrinol (Lausanne) 11:74 

26.    Srinivas US, Tan BWQ, Vellayappan BA, Jeyasekharan AD (2019) ROS and the DNA damage response in cancer. Redox Biol 25:101084 

27.    Finkel T, Holbrook NJ (2000) Oxidants, oxidative stress and the biology of ageing. Nature 408:239–247 

28.    Sendur OF, Turan Y, Tastaban E, Serter M (2009) Antioxidant status in patients with osteoporosis: a controlled study. Joint Bone Spine 76:514–8 

29.    Lean JM, Jagger CJ, Kirstein B et al (2005) Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation. Endocrinology 146:728-735 

30.    Bellanti F, Matteo M, Rollo T et al (2013) Sex hormones modulate circulating antioxidant enzymes: impact of estrogen therapy. Redox Biol 1:340–346 

31.    Yousefzadeh G, Larijani B, Mohammadirad A et al (2006) Heshmat R, Dehghan G, Rahimi R, Abdollahi M. Determination of oxidative stress status and concentration of TGF-beta 1 in the blood and saliva of osteoporotic subjects. Ann N Y Acad Sci 1091:142–50 

32.    Lean JM, Davies JT, Fuller K et al (2003) A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest 112(6):915–23 

33.    Filaire E, Toumi H (2012) Reactive oxygen species and exercise on bone metabolism: friend or enemy? Joint Bone Spine 79(4):341–6 

34.    Almeida M, Martin-Millan M, Ambrogini E (2010) Estrogens attenuate oxidative stress and the differentiation and apoptosis of osteoblasts by DNA-binding-independent actions of the ERalpha. J Bone Miner Res 25(4):769–81 

35.    Lean JM, Jagger CJ, Kirstein B et al (2005) Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation. Endocrinology 146(2):728–35 

36.    Baek KH, Oh KW, Lee WY (2010) Association of oxidative stress with postmenopausal osteoporosis and the effects of hydrogen peroxide on osteoclast formation in human bone marrow cell cultures. Calcif Tissue Int 87(3):226–35 

37.    Golbidi S, Li H, Laher I (2018) Oxidative Stress: A Unifying Mechanism for Cell Damage Induced by Noise, (Water-Pipe) Smoking, and Emotional Stress-Therapeutic Strategies Targeting Redox Imbalance. Antioxid Redox Signal 28(9):741–759 

38.    Mori G, D'Amelio P, Faccio R, Brunetti G (2013) The Interplay between the bone and the immune system. Clin Dev Immunol 720504 

39.    Guder C, Gravius S, Burger C et al (2020) Osteoimmunology: A Current Update of the Interplay Between Bone and the Immune System. Front Immunol 11:58 

40.    Ikeuchi T, Moutsopoulos NM (2022) Osteoimmunology in periodontitis; a paradigm for Th17/IL-17 inflammatory bone loss. Bone 163:116500 

41.    Barbato L, Francioni E, Bianchi M et al (2015) Periodontitis and bone metabolism. Clin Cases Miner Bone Metab 12(2):174–7 

42.    Brunetti G, Colucci S, Pignataro P et al (2005) T Cells Support Osteoclasto-genesis in an In Vitro Model Derived From Human Periodontitis Patients. J Periodontol 76:1675–1680 

43.    Sirisereephap K, Maekawa T, Tamura H et al (2022) Osteoimmunology in Periodontitis: Local Proteins and Compounds to Alleviate Periodontitis. Int J Mol Sci 23(10):5540 

44.    Ando Y, Tsukasaki M, Huynh NC et al (2024) The neutrophil-osteogenic cell axis promotes bone destruction in periodontitis. Int J Oral Sci 16(1):18 

45.    Su L, Zheng J, Wang Y, Zhang W, Hu D (2019) Emerging progress on the mechanism and technology in wound repair. Biomedicine & Pharmacotherapy 117:109191 

46.    Ribatti D, Crivellato E (2009) Immune cells and angiogenesis. J Cell Mol Med 13(9A):2822–33 

47.    Brylka LJ, Schinke T (2019) Chemokines in Physiological and Pathological Bone Remodeling. Front Immunol 10:2182 

48.    Schmidt-Bleek K, Kwee BJ, Mooney DJ, Duda GN (2015) Boon and Bane of Inflammation in Bone Tissue Regeneration and Its Link with Angiogenesis. Tissue Eng Part B Rev 21(4):354–64 

49.    Motoki DS, Mulliken JB (1990) The healing of bone and cartilage. Clin Plast Surg 17(3):527–44 

50.    Tsukasaki M, Takayanagi H (2019) Osteoimmunology: evolving concepts in bone-immune interactions in health and disease. Nat Rev Immunol 19(10):626–642 

51.    Liu R, Nikolajczyk BS (2019) Tissue Immune Cells Fuel Obesity-Associated Inflammation in Adipose Tissue and Beyond. Front Immunol 10:1587 

52.    Murray CE, Coleman CM (2019) Impact of Diabetes Mellitus on Bone Health. Int J Mol Sci 20(19):4873 

53.    Karam BS, Chavez-Moreno A, Koh W et al (2017) Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes. Cardiovasc Diabetol 16(1):120 

54.    Sawa M, Ushiyama A, Inaba Y, Hattori K (2022) Increased oxidative stress and effects on inflammatory cytokine secretion by heated tobacco products aerosol exposure to mice. Biochem Biophys Res Commun 610:43–48 

55.    Javed F, Rahman I, Romanos GE (2000) Tobacco-product usage as a risk factor for dental implants. Periodontol 81(1):48–56 

56.    Demoly P, Adkinson NF, Brockow K et al (2014) International Consensus on drug allergy. Allergy 69(4):420–37 

57.    French D, Noroozi M, Shariati B, Larjava H (2016) Clinical retrospective study of self-reported penicillin allergy on dental implant failures and infections. Quintessence Int 47(10):861–870 

58.    Basma HS, Misch CM (2021) Extraction Socket Grafting and Ridge Augmentation Failures Associated with Clindamycin Antibiotic Therapy: A Retrospective Study. Int J Oral Maxillofac Implants 36(1):122–25 

59.    Bozzetto S, Carraro S, Giordano G (2012) Asthma, allergy and respiratory infections: the vitamin D hypothesis. Allergy 67(1):10–7 

60.    Holick MF (2007). Vitamin D deficiency. N Engl J Med 357(3):266–81 

61.    Bikle DD (2014) Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol 21(3):319–29. doi: 10.1016/j.chembiol.2013.12.01 

62.    Chen L, Yang R, Qiao W et al (2019) 1,25-Dihydroxyvitamin D exerts an antiaging role by activation of Nrf2-antioxidant signaling and inactivation of p16/p53-senescence signaling. Aging Cell18(3):e12951 

63.    Liu PT, Stenger S, Li H, Wenzel L et al (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311(5768):1770–3 

64.    Wang Q, He Y, Shen Y et al (2014) Vitamin D inhibits COX-2 expression and inflammatory response by targeting thioesterase superfamily member 4. J Biol Chem 289(17):11681–11694 

65.    Zhou A, Hyppönen E (2023) Vitamin D deficiency and C-reactive protein: a bidirectional Mendelian randomization study. Int J Epidemiol 52(1):260–271 

66.    Werny JG, Sagheb K, Diaz L (2022) Does vitamin D have an effect on osseointegration of dental implants? A systematic review. Int J Implant Dent 8(1):16 

67.    Bazal-Bonelli S, Sánchez-Labrador L, Cortés-Bretón Brinkmann J et al (2022) Influence of Serum Vitamin D Levels on Survival Rate and Marginal Bone Loss in Dental Implants: A Systematic Review. Int J Environ Res Public Health 19(16):10120 

68.    Guido Mangano F, Ghertasi Oskouei S, Paz A et al (2018) Low serum vitamin D and early dental implant failure: Is there a connection? A retrospective clinical study on 1740 implants placed in 885 patients. J Dent Res Dent Clin Dent Prospects 12(3):174–182 

69.    Choukroun J, Khoury G, Khoury F et al (2014) Two neglected biologic risk factors in bone grafting and implantology: high low-density lipoprotein cholesterol and low serum vitamin D. J Oral Implantol 40(1):110–4 

70.    Mandal CC (2015) High Cholesterol Deteriorates Bone Health: New Insights into Molecular Mechanisms. Front Endocrinol (Lausanne). 6:165 

71.    Brodeur MR, Brissette L, Falstrault L et al (2008) Influence of oxidized low-density lipoproteins (LDL) on the viability of osteoblastic cells. Free Radic Biol Med 44(4):506-17 

72.    Brodeur MR, Brissette L, Falstrault L, Moreau R (2008) HDL3 reduces the association and modulates the metabolism of oxidized LDL by osteoblastic cells: a protection against cell death. J Cell Biochem 105(6):1374–85 

73.    Keuroghlian A, Barroso ADV, Kirikian G et al (2015) The effects of hyperlipidemia on implant osseointegration in the mouse femur. J Oral Implantol 41(2):e7–e11 

74.    Truong TQ, Brodeur MR, Falstrault L et al (2009) Expression of caveolin-1 in hepatic cells increases oxidized LDL uptake and preserves the expression of lipoprotein receptors. J Cell Biochem 108(4):906–15 

75.    Yin W, Li Z, Zhang W (2019) Modulation of Bone and Marrow Niche by Cholesterol. Nutrients 11(6):1394 

76.    Fujita T, Yoshimoto T, Kajiya M et al (2018) Regulation of defensive function on gingival epithelial cells can prevent periodontal disease. Jpn Dent Sci Rev 54(2):66–75 

77.    Tribble GD, Lamont RJ (2010) Bacterial invasion of epithelial cells and spreading in periodontal tissue. Periodontol 2000 52(1):68–83 

78.    Trindade R, Albrektsson T, Tengvall P, Wennerberg A (2016) Foreign Body Reaction to Biomaterials: On Mechanisms for Buildup and Breakdown of Osseointegration. Clin Implant Dent Relat Res 18(1):192–203 

79.    Anderson JM, Rodriguez A, Chang DT (2008) Foreign body reaction to biomaterials. Semin Immunol 20(2):86–100 

80.    Bracey DN, Cignetti NE, Jinnah AH et al (2020) Bone xenotransplantation: A review of the history, orthopedic clinical literature, and a single-center case series. Xenotransplantation 27(5):e12600 

81.    Luo L, Li P, Ren H et al (2021) Effects of bovine cancellous bone powder/poly amino acid composites on cellular behaviors and osteogenic performances. Biomed Mater  16(5) 

82.    Mammoto A, Connor KM, Mammoto T et al (2009) A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature 457(7233):1103–8 

83.    Roccuzzo M, Roccuzzo A, Marruganti C, Fickl S (2023) The importance of soft tissue condition in bone regenerative procedures to ensure long-term peri-implant health. Periodontol 2000 

84.    Ramanauskaite A, Schwarz F, Sader R (2022) Influence of width of keratinized tissue on the prevalence of peri-implant diseases: A systematic review and meta-analysis. Clin Oral Implants Res Suppl 23:8–31 

85.    Tian Y, Ma X, Yang C et al (2017) The Impact of Oxidative Stress on the Bone System in Response to the Space Special Environment. Int J Mol Sci 18(10):2132 

86.    Cohn LA (1991) The influence of corticosteroids on host defence mechanisms. J Vet Intern Med 5(2):95–104 

87.    Kuchar E, Karlikowska-Skwarnik M, Wawrzuta D (2022) Anti-Inflammatory Therapy of Infections. Encyclopedia of Infection and Immunity 791–7 

88.    Morganti P, Fabrizi G, Bruno C (2004) Protective effects of oral antioxidants on skin and eye function. Skinmed 3(6):310–6 

89.    McCarty MF, Lewis Lujan L, Iloki Assanga S (2022) Targeting Sirt1, AMPK, Nrf2, CK2, and Soluble Guanylate Cyclase with Nutraceuticals: A Practical Strategy for Preserving Bone Mass. Int J Mol Sci 23(9):4776 

90.    Benjamin M. Savasky, David P. Mascotti (2018) Naren Patel, and Edgardo Rodriguez-Collazo. Nutritional and Pharmacological Effects on Oxidative Stress in Soft Tissue and Bone Remodeling. Journal of Nutrition and Metabolism Volume 4183407 

91.    Holick MF, Binkley NC, Bischoff-Ferrari HA et al (2011) Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–30 

92.    Carr AC, Maggini S (2017) Vitamin C and Immune Function. Nutrients 9(11):1211 

93.    Gęgotek A, Skrzydlewska E (2022) Antioxidative and Anti-Inflammatory Activity of Ascorbic Acid. Antioxidants (Basel) 11(10):1993 

94.    Li X, Tang L, Lin YF, Xie GF (2018) Role of vitamin C in wound healing after dental implant surgery in patients treated with bone grafts and patients with chronic periodontitis. Clin Implant Dent Relat Res 20(5):793–798 

95.    Ustianowski Ł, Ustianowska K, Gurazda K (2023) The Role of Vitamin C and Vitamin D in the Pathogenesis and Therapy of Periodontitis-Narrative Review. Int J Mol Sci 24(7):6774 

96.    Chitimus DM, Popescu MR, Voiculescu SE et al (2020) Melatonin's Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease. Biomolecules 10(9):1211 

97.    Wu X, Qiao S, Wang W et al (2021) Melatonin prevents peri implantitis via suppression of TLR4/NF-κB. Acta Biomater 134:325–336 

98.    O'Connor JP, Kanjilal D, Teitelbaum M, Lin SS, Cottrell JA (2020) Zinc as a Therapeutic Agent in Bone Regeneration. Materials (Basel) 13(10):2211 

99.    Hsu E, Pacifici R (2018) From Osteoimmunology to Osteomicrobiology: How the Microbiota and the Immune System Regulate Bone. Calcif Tissue Int 102(5):512–521 

100.    Akbari S, Rasouli-Ghahroudi AA (2018) Vitamin K and Bone Metabolism: A Review of the Latest Evidence in Preclinical Studies. Biomed Res Int 4629383 

101.    Vallibhakara SA, Nakpalat K, Sophonsritsuk A et al (2021) Effect of Vitamin E Supplement on Bone Turnover Markers in Postmenopausal Osteopenic Women: A Double-Blind, Randomized, Placebo-Controlled Trial. Nutrients 13(12):4226 

102.    Rondanelli M, Faliva MA, Infantino V et al (2021) Copper as Dietary Supplement for Bone Metabolism: A Review. Nutrients 13(7):2246 

103.    Veronese N, Pizzol D, Smith L et al (2022) Effect of Magnesium Supplementation on Inflammatory Parameters: A Meta-Analysis of Randomized Controlled Trials. Nutrients 14(3):679 

104.    Bao M, Zhang K, Wei Y et al (2020) Therapeutic potentials and modulatory mechanisms of fatty acids in bone. Cell Prolif 53(2):e12735 

105.    Nastri L, Moretti A, Migliaccio S (2020) Do Dietary Supplements and Nutraceuticals Have Effects on Dental Implant Osseointegration? A Scoping Review. Nutrients 12(1):268 

106.    Keuroghlian A, Barroso AD, Kirikian G et al (2015) The effects of hyperlipidemia on implant osseointegration in the mouse femur. J Oral Implantol 41(2):e7–e11 

107.    Xing YW, Liu KZ (2021) Azithromycin inhibited oxidative stress and apoptosis of high glucose-induced podocytes by inhibiting STAT1 pathway. Drug Dev Res 82(7):990–998 

108.    McDonald PJ, Pruul H (1991) Phagocyte uptake and transport of azithromycin. Eur J Clin Microbiol Infect Dis 10(10):828–33 

109.    Gibson M, Walters JD (2020) Inhibition of neutrophil inflammatory mediator expression by azithromycin Clin Oral Investig 24(12):4493-4500 

110.    Duve C (1967) Influence of glucagon, an inducer of cellular autophagy, on some physical properties of rat liver lysosomes. J Cell Biol 33(2):437–49 

111.    Ohsumi Y, Mizushima N (2004) Two ubiquitin-like conjugation systems essential for autophagy. Semin Cell Dev Biol 15(2):231-236 

112.    Emmons R, Niemiro GM, De Lisio M (2016) Exercise as an Adjuvant Therapy for Hematopoietic Stem Cell Mobilization. Stem Cells Int 2016:7131359 

113.    Stanaway FF, Gnjidic D, Blyth FM et al (2011) How fast does the Grim Reaper walk? Receiver operating characteristics curve analysis in healthy men aged 70 and over. BMJ. 2011 Dec 15;343:d7679 

114.    Choukroun J, Adda F, Shoeffler C, Vervelle A (2001) PRF platelet Rich Fibrin: an opportunity in implantology. Implantodontie 

115.    Nasirzade J, Kargarpour Z, Hasannia S et al (2020) Platelet-rich fibrin elicits an anti-inflammatory response in macrophages in vitro. J Periodontol 91(2):244–252 

116.    Kargarpour Z, Nasirzade J, Strauss FJ et al (2020) Platelet-rich fibrin suppresses in vitro osteoclastogenesis. J Periodontol 91(3):413–421 

117.    Kargarpour Z, Nasirzade J, Di Summa F et al (2020) Platelet-Rich Fibrin Can Neutralize Hydrogen Peroxide-Induced Cell Death in Gingival Fibroblasts. Antioxidants (Basel) 9(6):560 

118.    Fujioka-Kobayashi M, Miron RJ, Hernandez M et al (2017) Optimized Platelet-Rich Fibrin With the Low-Speed Concept: Growth Factor Release, Biocompatibility, and Cellular Response. J Periodontol 88(1):112–121 

119.    Wang HL, Boyapati L (2006) "PASS" principles for predictable bone regeneration. Implant Dent 15(1):8–17